Brand Engagement shares surge 43.33% premarket after securing $250K pharma AI development deal with top-10 global client.

Brand Engagement Network (BNAI) surged 43.33% in premarket trading following the announcement of a $250,000 revenue-generating Vendor Services Project Agreement with a global advertising agency for a top-10 pharmaceutical client. The deal, disclosed in a December 29 press release, involves developing a custom AI engagement solution for a prescription drug, with recurring license fees anticipated in Q1 2026. The company also highlighted its expanding healthcare vertical through the Skye Salud AI platform in Mexico and existing Latin American partnerships, reinforcing its growth trajectory. The CEO emphasized the strategic importance of secure AI in healthcare, aligning with the stock’s sharp rise as investors reacted positively to near-term revenue visibility and long-term market expansion in a high-growth sector.